MediWound Ltd.
MDWDDrugs in Pipeline
8
Phase 3 Programs
4
Upcoming Catalysts
2
Next Catalyst
Aug 13, 2026
10dMarket Overview
Stock performance and key metrics
2 upcoming, 0 past
MDWD Earnings Report
EPS Est: $-0.76 | FQ end 2026-06 | Call: 2026-08-13 15:00:00
1 more catalyst beyond 14 days
Start a 48-hour free trial to see all upcoming catalysts
DGD
Burn
Gel Vehicle
Thermal Burns
EscharEx (EX-03)
Venous Leg Ulcer (VLU)
NexoBrid
Thermal Burns
EscharEx
Hard to Heal Wounds
EscharEx (5% EX-02 formulation)
Venous Leg Ulcer
EscharEx (EX-02 formulation)
Venous Leg Ulcer
EscharEx 5% (EX-02 formulation)
Superficial Basal Cell Carcinoma
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
DGD | Phase 3 | Burn | - | - |
Gel Vehicle | Phase 3 | Thermal Burns | - | - |
EscharEx (EX-03) | Phase 3 | Venous Leg Ulcer (VLU) | - | - |
NexoBrid | Phase 3 | Thermal Burns | - | - |
EscharEx | Phase 2 | Hard to Heal Wounds | - | - |
EscharEx (5% EX-02 formulation) | Phase 2 | Venous Leg Ulcer | - | - |
EscharEx (EX-02 formulation) | Phase 2 | Venous Leg Ulcer | - | - |
EscharEx 5% (EX-02 formulation) | Phase 2 | Superficial Basal Cell Carcinoma | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in MediWound Ltd.'s drug pipeline?→
CatalystAlert tracks 8 drug candidates in MediWound Ltd.'s (MDWD) pipeline across Phase 3, Phase 2. Its lead program is DGD (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is MediWound Ltd.'s next FDA catalyst?→
MediWound Ltd.'s (MDWD) next tracked catalyst is a Earnings expected August 13, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track MDWD biotech catalysts?→
Add MDWD to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow MediWound Ltd.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.